Use of eucalyptol for enhancing skin permeation of bio-affecting agents
Patent 4560553 Issued on December 24, 1985. Estimated Expiration Date: November 21, 2003. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
514/11, Monocyclic424/45, Organic pressurized fluid514/14, 12 to 15 peptide repeating units in known peptide chain514/152, 3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) DOAI514/153, With stabilizer or preservative514/154, With an additional active ingredient (excludes reaction product or complex)514/155, Para-N-benzene - sulfoxy-N containing DOAI, and said benzene ring is not part of a polycyclo ring system514/192, 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.)514/197, 6-position substituent contains carbocyclic ring514/199, Penicillin G per se or salt thereof (e.g., procaine pencillin G, etc.)514/201, 7,7-di-substituted514/209, Alkyl, hydroxyalkyl, alkoxyalkyl, or alkanoyloxyakyl bonded directly to 3-position514/23, Carbohydrate (i.e., saccharide radical containing) DOAI514/236.2, Three or more ring hetero atoms in the additional hetero ring514/24, S-glycoside514/25, O-glycoside514/253.08, Having -C(=X)-, wherein X is chalcogen, bonded directly to carbon of the hetero ring of the quinoline ring system514/269, Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety514/27, Oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring514/29, The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.)514/31, The hetero ring has 20 or more ring carbons (e.g., nystatin, etc.)514/311, Quinolines (including hydrogenated)514/312, Chalcogen attached directly to the six-membered hetero ring by nonionic bonding514/317, Additional ring containing514/358, The ring nitrogen of the six-membered hetero ring is pentavalent (e.g., quaternary pyridinium salt, etc.)514/365, 1,3-thiazoles (including hydrogenated)514/37, The nitrogen atoms are in N-C(=N)-N groups (e.g., streptomycin, etc.)514/380, Chalcogen or nitrogen bonded directly to ring carbon of the oxazole ring514/389, Divalent chalcogen or acyclic nitrogen double bonded directly at both 2- and 4- positions, or tautomeric equivalent (e.g., hydantoin, etc.)514/390, Chalcogen or nitrogen bonded directly at 1-, 3-, or 5-position by nonionic bonding514/392, Divalent chalcogen or acyclic nitrogen double bonded at 2-position, or tautomeric equivalent514/42, N-glycoside514/462, Spiro ring system514/50, 2,4-diketone pyrimidine or derivative (e.g., uracil, etc.)514/535, The nitrogen of the Z radical is directly bonded to a benzene ring which is directly bonded to the C(=O) group514/536, With an agent to enhance topical absorption or with a stabilizing agent514/553, Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI514/554, Amine addition salt of the acid514/555, Benzene ring in acid moiety514/561, Nitrogen other than as nitro or nitroso nonionically bonded514/567, Benzene ring nonionically bonded514/626, Nitrogen in R514/633, Amidoximes (i.e., N-C=N-O)514/636, Polyamidines514/646, Benzene ring containing514/652, Alkanol group only between the amino nitrogen and an ether oxygen which is bonded directly to the aryl ring or aryl ring system (i.e., aryloxy alkanol amines)514/653, Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)514/657, Bicyclo ring system514/667, C-O-group containing514/714, Peroxide DOAI514/735, Nuclear halogenated514/747, Carbocyclic514/853, DECONGESTANT514/99Oxygen containing hetero ring